Recurrence of herpes simplex encephalitis associated with temozolomide chemoradiation for malignant glioma: A case report and review of the literature

7Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Although herpes simplex encephalitis is not classically considered an opportunistic infection, reactivation of herpes simplex is being seen increasingly in patients with cancer or immunosuppression. The authors present a patient with malignant glioma and HSV-1 encephalitis whose PCR-proven encephalitis recurred after temozolomide (TMZ) chemoradiation despite acyclovir therapy, and summarize details of four other cases of HSV-1 encephalitis associated with TMZ. The similarity among these cases raises the likely need for longer treatment courses and/or oral suppressive therapy in patients at risk for herpes simplex infections who are receiving TMZ.

Cite

CITATION STYLE

APA

Christman, M. P., Turbett, S. E., Sengupta, S., Bakhadirov, K. U., Williamson, C. A., Nayak, L., … Katz, J. T. (2014). Recurrence of herpes simplex encephalitis associated with temozolomide chemoradiation for malignant glioma: A case report and review of the literature. Oxford Medical Case Reports, 2014(1), 1–4. https://doi.org/10.1093/omcr/omu001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free